Sarcasm? Baiting? The numbers are already groundbreaking. Iovance is doing what no other company has ever done with TIL therapy. Every treatment is groundbreaking this early in the commercialization given the complexity of what this company is doing.
And if you believe the markets are forward looking and you see a future for Iovance, then now would seem like the time to buy hand over fist. If only Iovance traded strictly on its own merit, we'd have much happier investors.
Your money, your rules, your decision.
Do your due diligence.
Good luck to IOVA longs.